Antibiotic Developments Insights
The panel combatting the rise of antibiotic resistance in UTIs
Rebekah Jordan sits down with Oliver Schacht, CEO of OpGen, to discuss the increasing prevalence of antibiotic resistance in Urinary Tract Infections (UTIs), and how OpGen’s Unyvero can quicken the AR diagnosis process. Read more
11 Aug 2022
Antimicrobial resistance: Here we go again
Why we should pay attention to the latest antimicrobial resistance research. Read more
17 Feb 2022
The future of combatting antimicrobial resistance
Oliver Schacht, CEO of OpGen looks at why technologies including artificial intelligence and machine learning could be key to combatting antimicrobial resistance. Read more
29 Nov 2021
AMR in Orthopedics – Benefits of topical treatment and latest advances
Michael Harris, chief executive officer of Biocomposites explores the threat of antibiotic resistance and how antibiotics are being used within the orthopaedics industry. Read more
7 Oct 2021
Improving our approach to fighting AMR
Oliver Schacht, CEO of precision medicine and genomics analysis company OpGen explores what we need to do to improve our fight against antimicrobial resistance (AMR). Read more
11 Aug 2021
The state of bioinformatics in the fight against AMR
Oliver Schacht, CEO of OpGen, Inc., examines the potential of bioinformatics in helping to fight antimicrobial resistance. Read more
27 Jan 2021
Glox Therapeutics awarded grant to accelerate development of precision antibiotics
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy). Read more
25 Nov 2024
Global study shows cefiderocol’s success in treating resistant infections
Shionogi & Co., Ltd. shared new data at IDWeek 2024 from the PROVE study, the largest global real-world evidence review of Fetroja/Fetcroja (cefiderocol). Read more
17 Oct 2024
WHO Report Shows Increase in HIV Drug Resistance to Dolutegravir
The World Health Organization’s (WHO) latest HIV Drug Resistance (HIVDR) Report tells us where drug resistance is growing and offers recommendations for countries to monitor and respond to the potential challenges. Read more
8 Mar 2024
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more
Proactive maintenance: The key to reliability, efficiency, and client success
Beccy Bell, associate director of laboratory services at testing and regulatory consultancy Broughton, delves into the critical role of maintenance strategies in achieving seamless operations. Read more
4 Feb 2025
Q&A: Honeywell introduces the TrackWise Life Sciences Platform
After Honeywell introduced the TrackWise Life Sciences Platform, European Pharmaceutical Manufacturer spoke to Sunil Pandita, VPGM of Honeywell Connected Industrials for more information. Read more
3 Feb 2025
CAR T-cell therapy reaches a turning point: Are we on the brink of first-line use?
Patent-filing research conducted by Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising treatments for various forms of cancer is nearing. Read more
31 Jan 2025
Q&A: Merck launches platform to tackle issues of counterfeiting
After Merck announced the launch of a beta version of M-Trust™, a secure cyber-physical trust platform, created to help solve the growing issues of product safety, traceability and counterfeiting, EPM asked some follow-ups questions to learn more. Read more
30 Jan 2025
How advances in cell sorting are enabling ultra-complex research
Dr. James McCracken, senior commercial product manager at Beckman Coulter Life Sciences, discusses how cell sorting is a popular and growing use of flow cytometry – and one that many researchers rely on specialists to perform. Read more
29 Jan 2025
Oncology dominates biopharma in business development and licensing
Anne Dhulesia, partner, Sean Dyson, partner, and Guy Stephens, manager, L.E.K. Consulting, discuss how oncology is the single largest therapeutic area for pharmaceutical sales worldwide. Read more
28 Jan 2025
Sponsored Content
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more